Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC a...
Prof Caicun Zhou - Shanghai Pulmonary Hospital, Shanghai, China
Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC at ASCO 2021 ( Prof Caicun Zhou - Shanghai Pulmonary Hospital, Shanghai, China )
16 Jul 2021
Lineage plasticity in lung cancer- biological and therapeutic implications
Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA
Lineage plasticity in lung cancer- biological and therapeutic implications ( Dr Triparna Sen - Memorial Sloan Kettering Cancer Center, New York, USA )
16 Jul 2021
CodeBreaK 100: Patient-reported outcomes evaluating sotorasib in KRAS p.G12C mNS...
Dr Alex Spira - Virginia Cancer Specialists Research Institute, Fairfax, USA
CodeBreaK 100: Patient-reported outcomes evaluating sotorasib in KRAS p.G12C mNSCLC ( Dr Alex Spira - Virginia Cancer Specialists Research Institute, Fairfax, USA )
6 Jul 2021
ASCO 2021: Lung roundup
Dr Luis Raez - Memorial Healthcare System, FL, USA
ASCO 2021: Lung roundup ( Dr Luis Raez - Memorial Healthcare System, FL, USA )
5 Jul 2021
Latest updates in exon 20 insertions focusing on targeted therapies, novel appro...
Dr Mathew Krebs, Dr Santiago Viteri, Dr Shirish Gadgeel and Prof Byoung Chul Cho
Latest updates in exon 20 insertions focusing on targeted therapies, novel approaches, and implications for patients ( Dr Mathew Krebs, Dr Santiago Viteri, Dr Shirish Gadgeel and Prof Byoung Chul Cho )
22 Jun 2021
Advances in lung cancer and current situation in Romania
Dr Serban Negru - University of Medicine and Pharmacy Victor Babes Timisoara, On...
Advances in lung cancer and current situation in Romania ( Dr Serban Negru - University of Medicine and Pharmacy Victor Babes Timisoara, OncoHelp Cancer Center )
21 Jun 2021
ALCSI: Raising lung cancer screening awareness in the US
Priyanka Senthil - American Lung Cancer Screening Initiative
ALCSI: Raising lung cancer screening awareness in the US ( Priyanka Senthil - American Lung Cancer Screening Initiative )
17 Jun 2021
Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC
Dr Christina Baik - University of Washington School of Medicine, Seattle, USA
Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC ( Dr Christina Baik - University of Washington School of Medicine, Seattle, USA )
11 Jun 2021
IMpower010: Atezolizumab versus best supportive care after adjuvant chemotherapy...
Prof Heather Wakelee - Stanford University, Stanford, USA
IMpower010: Atezolizumab versus best supportive care after adjuvant chemotherapy in resected NSCLC ( Prof Heather Wakelee - Stanford University, Stanford, USA )
11 Jun 2021
CodeBreaK100: Sotorasib in pretreated KRAS p.G12C mNSCLC
Dr Ferdinandos Skoulidis - MD Anderson Cancer Center, Houston, USA
CodeBreaK100: Sotorasib in pretreated KRAS p.G12C mNSCLC ( Dr Ferdinandos Skoulidis - MD Anderson Cancer Center, Houston, USA )
9 Jun 2021
Highlights from ASCO 2021
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ASCO 2021 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
8 Jun 2021
OncoAlert and ecancer ASCO roundup - Day 2
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer ASCO roundup - Day 2 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Jun 2021